MAO inhibitors (MAOIs) clinical trials
A class of medicines: the studies that test any of its 9 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones. In MeSH: Monoamine Oxidase Inhibitors.
Get an email when these change. Save the mao inhibitors (maois) studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Medicines in this class
Studies that test each. A study of two counts under both, and once above.
- Isocarboxazid
- 1
Studies by the year they started
122 studies that test it; most in 2007 (13)
| Year | Studies |
|---|---|
| 1994 | 2 |
| 1995 | 1 |
| 1997 | 1 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 2 |
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 13 |
| 2008 | 5 |
| 2009 | 9 |
| 2010 | 7 |
| 2011 | 11 |
| 2012 | 9 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 9 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 54 · Other 71
Newron Pharmaceuticals SPA (12) · Teva Branded Pharmaceutical Products R&D, Inc. (10) · National Institute on Drug Abuse (NIDA) (7) · Zambon SpA (5) · Takeda (4) · H. Lundbeck A/S (4) · New York State Psychiatric Institute (4) · Hoffmann-La Roche (4)
Studies
Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing one of them · 125
- Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor FluctuationsRecruitingPhase 3Universita di VeronaNCT07761936Written as Safinamide
- Precision Care for Major Depressive DisorderEnrolling by invitationPhase 4University of California, San FranciscoNCT06580041Written as Phenelzine
- Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate CancerCompletedPhase 2University of Southern CaliforniaNCT02217709Written as phenelzine sulfate
- Effect of Safinamide on Sleep Quality in Patients With Parkinson's DiseaseTerminatedPhase 4Alain KaelinNCT03968744Written as Safinamide
- The Effect of Tranexamic Acid in Endoscopic and Microscopic Ear Surgery Cases on Surgeon SatisfactionCompletedNot applicableTC Erciyes UniversityNCT06434636Written as Transamine 10% IV/IM Solution for Injection
- Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized PosturographyWithdrawnPhase 4New York Medical CollegeNCT07077187Written as Rasagiline 1 mg capsule
- Molecular Imaging Study of Harmine/DMT: a Basic Research ApproachCompletedPhase 1Insel Gruppe AG, University Hospital BernNCT06252506Written as N,N-dimethyltryptamine (DMT) + harmine
- Study of Harmine in Healthy SubjectsCompletedPhase 1James MurroughNCT05526430Written as Harmine Hydrochloride Capsules
- Efficacy and Safety of Rasagiline in Prodromal Parkinson's DiseaseWithdrawnPhase 2/3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05611372Written as Rasagiline
- A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South KoreaCompletedPhase 4Eisai Korea Inc.NCT05312632Written as Safinamide Mesilate
- Overnight Switch From Rasagiline To SafinamideCompletedPhase 4IRCCS San Raffaele RomaNCT03843944Written as Safinamide
- A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of LevodopaCompletedPhase 3Zambon SpANCT03881371Written as Safinamide
- Mindfulness and PsychedelicsCompletedEarly Phase 1Milan ScheideggerNCT05780216Written as DMT + harmine
- Image Parkinson's Disease Progression StudyCompletedPhase 2University of FloridaNCT02789020Written as Rasagiline
- Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult ParticipantsCompletedPhase 1CelgeneNCT04978298Written as Phenelzine
- Selegiline to Zelapar Switch Study in Parkinson Disease PatientsCompletedPhase 4Baylor College of MedicineNCT00640159Written as Zelapar
- Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy VolunteersCompletedPhase 1Ludwig-Maximilians - University of MunichNCT05938517Written as Selegiline-hydrochloride
- Effect of Safinamide on Parkinson's Disease Related Chronic PainCompletedPhase 4Zambon SpANCT03841604Written as Safinamide Methanesulfonate
- A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sCompletedPhase 3Pharma Two B Ltd.NCT03329508Written as Rasagiline 0.75 mg
- A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese VolunteersCompletedPhase 1Zambon SpANCT03887221Written as Safinamide 50 mg
See all 125 studies that test one of the mao inhibitors (maois) →